Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Agenus Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
AGEN
Nasdaq
8731
http://agenusbio.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Agenus Inc
Agenus to Host Investor Webcast to Review Late-Breaking Botensilimab and Balstilimab Data Presented at ESMO World GI Congress
- Jun 21st, 2022 12:30 pm
GSK’s RSV vaccine candidate for older adults, containing Agenus’ QS-21 STIMULON™ as part of GSK’s AS01 adjuvant, reports positive pivotal data supporting initiation of global regulatory submissions
- Jun 10th, 2022 12:00 pm
Does Agenus (NASDAQ:AGEN) Have A Healthy Balance Sheet?
- Jun 2nd, 2022 11:48 am
Agenus Advances Portfolio with 6 Clinical Collaborations
- May 31st, 2022 12:30 pm
Agenus Announces Virtual Annual Shareholders Meeting
- May 25th, 2022 12:30 pm
Agenus to Participate at Jefferies Healthcare Conference
- May 25th, 2022 12:30 pm
Agenus Announces Late-Breaking Oral Presentation at ESMO-GI and Strategies to Advance Botensilimab
- May 24th, 2022 12:30 pm
3 Biotech Stocks With a Cash Pile Higher Than Their Valuations
- May 21st, 2022 12:00 pm
Agenus (AGEN) Reports Q1 Loss, Tops Revenue Estimates
- May 10th, 2022 1:15 pm
Agenus Corporate Update and First Quarter 2022 Financial Report
- May 10th, 2022 12:00 pm
Agenus to Provide Corporate Update and First Quarter 2022 Financial Report
- Apr 26th, 2022 12:30 pm
Why Adaptimmune Therapeutics, Agenus, and Sorrento Therapeutics Popped Today
- Apr 19th, 2022 7:43 pm
Agenus Presents Data on AGEN1571 (anti-ILT2) at AACR and Announces IND Clearance
- Apr 8th, 2022 5:00 pm
Agenus’ CD137 Agonist (AGEN2373) Advances in the Clinic, Triggering Milestone Payment from Gilead
- Apr 5th, 2022 12:30 pm
Targovax ASA and Agenus announce collaboration on mutant KRAS cancer vaccine adjuvanted with QS-21 STIMULON™
- Mar 7th, 2022 12:00 pm
Why Agenus Stock Is Crushing It Today
- Mar 2nd, 2022 7:10 pm
Agenus (AGEN) Q4 2021 Earnings Call Transcript
- Mar 1st, 2022 11:00 pm
Agenus (AGEN) Reports Q4 Loss, Lags Revenue Estimates
- Mar 1st, 2022 2:55 pm
Agenus Corporate Update and Fourth Quarter & Full Year 2021 Financial Report
- Mar 1st, 2022 1:00 pm
Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2021 Financial Report
- Feb 15th, 2022 1:30 pm
Scroll